New drug review processes would be accelerated and completed in 120 days in response to a US plan to raise pharmaceutical tariffs, the Ministry of Health and Welfare said yesterday.
Food and Drug Administration (FDA) Deputy Director-General Wang Der-yuan (王德原) yesterday told a news conference that measures have been taken to optimize new medicine review processes and help pharmaceutical companies obtain drug permit licenses as soon as possible.
Such processes normally take about 360 days to complete, if the new medicine is a new chemical entity (NCE) — a drug with new chemicals as principal components — or a drug made from biological sources, also known as biologics.
Photo: AP
However, NCEs or biologics considered important for pediatric treatments and serious diseases, as well as breakthrough therapies can have their review prioritized, with the process shortened to 240 days, he said.
If an NCE or a biologic has been approved in two of the US, the EU or Japan, it is qualified for a “type 1 express review” and can have its review completed as fast as in 180 days, Wang said.
If it has been approved in the three areas with identical data on chemistry, manufacturing and controls, it is qualified for a “type 2 express review” and its review process could be completed in 120 days, he added.
The ministry would also continue to encourage pharmaceutical companies to diversify sources of bulk drugs or active pharmaceutical ingredients so that they would not rely on a single supplier, he said.
China and India are the two major sources of bulk drugs used in Taiwan’s pharmaceutical industry, he said.
The FDA has requested pharmaceutical companies to evaluate whether they should find more bulk drug sources, Wang said, adding that the agency would prioritize the review of new medicines relying on a single source.
Pharmaceutical companies should also use domestically made bulk drugs, although they are mostly more expensive and less adopted, he said.
The administration has compiled an inventory of all US-made pharmaceutical products and sent a notice to their permit license holders to fully understand the medicine supply chain situation and properly boost domestic medicine stocks, he said.
It would also check stocks of primary medicines, such as anti-cancer drugs, orphan drugs and biologics to promptly initiate an investigation and evaluation whenever there is a potential shortage, he said.
The FDA would ask manufacturers of substitute medicines to increase production, or launch a drug import or manufacturing project, if necessary, he said.
Pharmaceutical companies can propose price adjustments to stabilize the market if changes in the global supply chain cause a surge in drug production costs, he said.
The ministry would continue to promote the application of generic drugs and biosimilars — biologics with similar structure and functions of a reference biologic made by another company — to bolster domestically made new medicines, Wang added.
LOUD AND PROUD Taiwan might have taken a drubbing against Australia and Japan, but you might not know it from the enthusiasm and numbers of the fans Taiwan might not be expected to win the World Baseball Classic (WBC) but their fans are making their presence felt in Tokyo, with tens of thousands decked out in the team’s blue, blowing horns and singing songs. Taiwanese fans have packed out the Tokyo Dome for all three of their games so far and even threatened to drown out home team supporters when their team played Japan on Friday. They blew trumpets, chanted for their favorite players and had their own cheerleading squad who dance on a stage during the game. The team struggled to match that exuberance on the field, with
Taiwanese paleontologists have discovered fossil evidence that pythons up to 4m long inhabited Taiwan during the Pleistocene epoch, reporting their findings in the international scientific journal Historical Biology. National Taiwan University (NTU) Institute of Ecology and Evolutionary Biology associate professor Tsai Cheng-hsiu (蔡政修) led the team that discovered the largest snake fossil ever found in Taiwan. The single trunk vertebra was discovered in Tainan at the Chiting Formation, dated to between 400,000 and 800,000 years ago in the Middle Pleistocene, the paper said. The area also produced Taiwan’s first avian fossil, as well as crocodile, mammoth, saber-toothed cat and rhinoceros fossils, it said. Discoveries
Taiwanese paleontologists have discovered fossil evidence that pythons up to 4m long inhabited Taiwan during the Pleistocene epoch, reporting their findings in the international scientific journal Historical Biology. National Taiwan University (NTU) Institute of Ecology and Evolutionary Biology associate professor Tsai Cheng-hsiu (蔡政修) led the team that discovered the largest snake fossil ever found in Taiwan. A single trunk vertebra was discovered in Tainan at the Chiting Formation, dated to between 800,000 to 400,000 years ago in the Middle Pleistocene, the paper said. The area also produced Taiwan’s first avian fossil, as well as crocodile, mammoth, sabre-toothed cat and rhinoceros fossils, it said. Discoveries
Whether Japan would help defend Taiwan in case of a cross-strait conflict would depend on the US and the extent to which Japan would be allowed to act under the US-Japan Security Treaty, former Japanese minister of defense Satoshi Morimoto said. As China has not given up on the idea of invading Taiwan by force, to what extent Japan could support US military action would hinge on Washington’s intention and its negotiation with Tokyo, Morimoto said in an interview with the Liberty Times (sister paper of the Taipei Times) yesterday. There has to be sufficient mutual recognition of how Japan could provide
RSS